EXPERIMENTAL IMMUNOLOGY
The associations between interleukin 10 polymorphisms and susceptibility to autoimmune uveitis – a meta-analysis
1
Division of Rheumatology, Korea University Medical Centre, Seoul, South Korea
Submission date: 2017-04-09
Final revision date: 2017-05-21
Acceptance date: 2017-05-29
Publication date: 2019-09-30
Cent Eur J Immunol 2019;44(3):246-252
KEYWORDS
ABSTRACT
Autoimmune uveitis is an ocular inflammatory disease that is associated with genetic factors. Interleukin 10 (IL-10) is an immune-regulatory cytokine of autoimmune diseases. IL-10 is considered a candidate gene for uveitis. We evaluate the association of IL-10 with susceptibility to autoimmune uveitis. The results from seven studies were pooled in the meta-analysis, covering a total of 2893 cases of uveitis and 4873 controls. Published literature from MEDLINE and Embase was retrieved. Meta-analyses were conducted on the associations between autoimmune uveitis and the -1082 A/G and -819 C/T polymorphisms of the IL-10 gene. The meta-analysis revealed no association between uveitis and the IL-10 -1082 A allele (OR = 0.91, 95% CI = 0.64-1.30, p = 0.62). The recessive, dominant, and homozygous models of the IL-10 -1082 A/G allele also suggested no association between autoimmune uveitis and each genotype. The meta-analysis revealed significant association between uveitis and the -892 C allele (OR = 0.81, 95% CI = 0.67-0.98, p = 0.03). In addition, significant association was found in homozygous models (OR = 0.58, 95% CI = 0.36-0.92, p = 0.02). However, the dominant and recessive models of the IL-10 -819 C/T polymorphisms showed no association between uveitis and each genotype. This meta-analysis showed that the -1082 A/G polymorphisms of IL-10 were not associated with autoimmune uveitis, but the -819 C/T polymorphisms were significantly associated with uveitis.
REFERENCES (30)
1.
Selmi C (2014): Diagnosis and classification of autoimmune uveitis. Autoimmun Rev 13: 591-594.
2.
Agrawal R, Iyer J, Connolly J, et al. (2014): Cytokines and biologics in non-infectious autoimmune uveitis: bench to bedside. Indian J Ophthalmol 62: 74-81.
3.
Horai R, Caspi RR (2011): Cytokines in autoimmune uveitis. J Interferon Cytokine Res 31: 733-744.
4.
Lin P (2015): Targeting interleukin-6 for noninfectious uveitis. Clin Ophthalmol 9: 1697-1702.
5.
Cordero-Coma M, Sobrin L (2015): Anti-tumor necrosis factor-alpha therapy in uveitis. Surv Ophthalmol 60: 575-589.
6.
Takeuchi M (2013): A systematic review of biologics for the treatment of noninfectious uveitis. Immunotherapy 5: 91-102.
7.
Ghasemi H, Ghazanfari T, Yaraee R, et al. (2012): Roles of IL-10 in ocular inflammations: a review. Ocul Immunol Inflamm 20: 406-418.
8.
Atan D, Fraser-Bell S, Plskova J, et al. (2010): Cytokine polymorphism in noninfectious uveitis. Invest Ophthalmol Vis Sci 51: 4133-4142.
9.
Lv C, Wang Y, Wang J, et al. (2011): Association of Interleukin-10 gene polymorphisms with ankylosing spondylitis. Clin Invest Med 34: E370.
10.
Jung JH, Song GG, Lee YH (2015): Meta-Analysis of Associations Between Interleukin-10 Polymorphisms and Susceptibility to Vasculitis. Immunol Invest 44: 553-565.
11.
Jabs DA, Nussenblatt RB, Rosenbaum JT (2005): Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140: 509-516.
12.
Moher D, Liberati A, Tetzlaff J, et al. (2010): Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8: 336-341.
13.
Higgins JP, Thompson SG (2002): Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
14.
Egger M, Smith GD, Phillips AN (1997): Meta-analysis: principles and procedures. BMJ 315: 1533-1537.
15.
DerSimonian R, Laird N (1986): Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
16.
Hu J, Hou S, Zhu X, et al. (2015): Interleukin-10 gene polymorphisms are associated with Behcet’s disease but not with Vogt-Koyanagi-Harada syndrome in the Chinese Han population. Mol Vis 21: 589-603.
17.
Lindner E, Steinwender G, Plainer S, et al. (2013): Role of IL-10 gene polymorphisms in intermediate and HLA-B27-associated uveitis. Acta Ophthalmol 91: e415-417.
18.
Talaat RM, Ashour ME, Bassyouni IH, et al. (2014): Polymorphisms of interleukin 6 and interleukin 10 in Egyptian people with Behcet’s disease. Immunobiology 219: 573-582.
19.
Dilek K, Ozcimen AA, Saricaoglu H, et al. (2009): Cytokine gene polymorphisms in Behcet’s disease and their association with clinical and laboratory findings. Clin Exp Rheumatol 27: S73-78.
20.
Stanford MR, Vaughan RW, Kondeatis E, et al. (2005): Are cytokine gene polymorphisms associated with outcome in patients with idiopathic intermediate uveitis in the United Kingdom? Br J Ophthalmol 89: 1013-1016.
21.
Yu H, Zheng M, Zhang L, et al. (2017): Identification of susceptibility SNPs in IL10 and IL23R-IL12RB2 for Behcet’s disease in Han Chinese. J Allergy Clin Immunol 139: 621-627.
22.
Atan D, Turner SJ, Kilmartin DJ, et al. (2005): Cytokine gene polymorphism in sympathetic ophthalmia. Invest Ophthalmol Vis Sci 46: 4245-4250.
23.
Crawley E, Kay R, Sillibourne J, et al. (1999): Polymorphic haplotypes of the interleukin-10 5’ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 42: 1101-1108.
24.
Kim M, Won JY, Choi SY, et al. (2016): Anti-TNFαlpha Treatment for HLA-B27-Positive Ankylosing Spondylitis-Related Uveitis. Am J Ophthalmol 170: 32-40.
25.
Levy-Clarke G, Jabs DA, Read RW, et al. (2014): Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology 121: 785-796.
26.
Liu W, Wu YH, Zhang L, et al. (2016): Efficacy and safety of TNF-αlpha inhibitors for active ankylosing spondylitis patients: Multiple treatment comparisons in a network meta-analysis. Sci Rep 6: 32768.
27.
Desbois AC, Addimanda O, Bertrand A, et al. (2016): Efficacy of Anti-TNF in Severe and Refractory Neuro-Behcet Disease: An Observational Study. Medicine (Baltimore) 95: e3550.
28.
Amber KT, Bloom R, Mrowietz U, et al. (2015): TNF-αlpha: a treatment target or cause of sarcoidosis? J Eur Acad Dermatol Venereol 29: 2104-2111.
29.
Amir O, Rogowski O, David M, et al. (2010): Circulating interleukin-10: association with higher mortality in systolic heart failure patients with elevated tumor necrosis factor-alpha. Isr Med Assoc J 12: 158-162.
30.
Wallace GR, Kondeatis E, Vaughan RW, et al. (2007): IL-10 genotype analysis in patients with Behcet’s disease. Hum Immunol 68: 122-127.
Share
RELATED ARTICLE
| eISSN: | 1644-4124 |
| ISSN: | 1426-3912 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
